Modulation of the CCR6-CCL20 axis: a potential therapeutic target in inflammation and cancer R Ranasinghe, R Eri Medicina 54 (5), 88, 2018 | 82 | 2018 |
Cisplatin for cancer therapy and overcoming chemoresistance R Ranasinghe, ML Mathai, A Zulli Heliyon 8 (9), 2022 | 78 | 2022 |
Pleiotropic immune functions of chemokine receptor 6 in health and disease R Ranasinghe, R Eri Medicines 5 (3), 69, 2018 | 55 | 2018 |
Revisiting the therapeutic potential of tocotrienol R Ranasinghe, M Mathai, A Zulli Biofactors 48 (4), 813-856, 2022 | 43 | 2022 |
A synopsis of modern-day colorectal cancer: Where we stand R Ranasinghe, M Mathai, A Zulli Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (2), 188699, 2022 | 32 | 2022 |
Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress R Ranasinghe, M Mathai, A Zulli Life Sciences 318, 121466, 2023 | 28 | 2023 |
CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years? R Ranasinghe, R Eri Gastrointestinal Disorders 1 (1), 57-74, 2018 | 15 | 2018 |
CCR6–CCL20-Mediated immunologic pathways in inflammatory bowel disease R Ranasinghe, R Eri Gastrointestinal Disorders 1 (1), 15-29, 2018 | 11 | 2018 |
Ccr6 Deficiency Attenuates Spontaneous Chronic Colitis in Winnie R Ranasinghe, R Fernando, AP Perera, M Shastri, W Basheer, P Scowen, ... Gastrointestinal Disorders 2 (1), 27-47, 2020 | 2 | 2020 |
Predictive markers of early endothelial dysregulation in type-1 diabetes: a meta-analysis R Ranasinghe, M Mathai, MA Alshawsh, A Zulli, R Ranasinghe Acta Diabetologica, 1-23, 2024 | | 2024 |
Updated Risk Factors of Early Endothelial Deregulation in Type-1 Diabetes: A Meta-Analysis R Ranasinghe, M Mathai, MA Alshawsh, A Zulli Preprints, 2024 | | 2024 |
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm R Ranasinghe, M Mathai, MA Alshawsh, A Zulli Heliyon 10 (7), 2024 | | 2024 |
The Role of Cc Chemokine Receptor Six (Ccr6) in Prospective Immune Modulation Therapy in Ibd R Ranasinghe J Mucosal Immunol Res 5: 128 5 (1), 128, 2021 | | 2021 |